Hi everyone,
The FDA is asking for public comments on the draft guidance issued on Cannabis and Cannabis derived compounds. Initial comments thus far have centered around the debate for culture vs. non-culture based testing with Medicinal Genomics in favor of non-culuture based testing. The results of their testing can be found here: https://www.medicinalgenomics.com/potentially-harmful-shortcomings-of-culture-based-microbial-testing/
More information and a link to public comment section at Regulation.gov below:
https://advocacy.sba.gov/2020/07/23/fda-issues-draft-guidance-on-cannabis-and-cannabis-derived-compounds-quality-considerations-for-clinical-research/